{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:50:09Z","timestamp":1791453009228,"version":"4.3.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite paucity of data, it is common practice to discontinue metformin before invasive coronary angiography due to an alleged risk of Metformin-Associated Lactic Acidosis (M-ALA). We aimed at assessing the safety of metformin continuation in diabetic patients undergoing coronary angiography in terms of significant increase in lactate levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this open-label, prospective, multicentre, single-arm trial, all diabetic patients undergoing coronary angiography with or without percutaneous coronary intervention at 3 European centers were screened for enrolment. The primary endpoint was the increase in lactate levels from preprocedural levels at 72-h after the procedure. Secondary endpoints included contrast associated-acute kidney injury (CA-AKI), M-ALA, and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>142 diabetic patients on metformin therapy were included. Median preprocedural lactate level was 1.8\u00a0mmol\/l [interquartile range (IQR) 1.3\u20132.3]. Lactate levels at 72\u00a0h after coronary angiography were 1.7\u00a0mmol\/l (IQR 1.3\u20132.3), with no significant differences as compared to preprocedural levels (p\u2009=\u20090.91; median difference\u2009=\u20090; IQR \u2212\u00a00.5 to 0.4\u00a0mmol\/l). One patient had 72-h levels \u2265\u20095\u00a0mmol\/l (5.3\u00a0mmol\/l), but no cases of M-ALA were reported. CA-AKI occurred in 9 patients (6.1%) and median serum creatinine and estimated glomerular filtration rate remained similar throughout the periprocedural period. At a median follow-up of 90\u00a0days (43\u2013150), no patients required hemodialysis and 2 patients died due to non-cardiac causes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In diabetic patients undergoing invasive coronary angiography, metformin continuation throughout the periprocedural period does not increase lactate levels and was not associated with any decline in renal function.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      : The study was registered at Clinicaltrials.gov (NCT04766008).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-01744-4","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T13:03:11Z","timestamp":1675688591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial"],"prefix":"10.1186","volume":"22","clinical-trial-number":[{"clinical-trial-number":"nct04766008","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mauro","family":"Chiarito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sanz-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Condello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Liccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Maurina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Avvedimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Regazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pagnotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Diez Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Reimers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"1744_CR1","unstructured":"World Diabetes Day. International diabetes federation. 2014. http:\/\/www.idf.org\/worlddiabetesday\/current-campaign."},{"key":"1744_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijcard.2016.03.088","volume":"214","author":"A Colombo","year":"2016","unstructured":"Colombo A, Godino C, Donahue M, Testa L, Chiarito M, Giulia A, et al. One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients Insight from the ASTUTE registry ( AmphilimuS iTalian mUlticenTre rEgistry ). Int J Cardiol. 2016;214:113\u201320.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1744_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193\u2013203.","journal-title":"Diabetes Care"},{"issue":"2","key":"1744_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","volume":"65","author":"R Defronzo","year":"2016","unstructured":"Defronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism. 2016;65(2):20\u20139.","journal-title":"Metabolism"},{"key":"1744_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000996","author":"S Bangalore","year":"2021","unstructured":"Bangalore S, Barsness GW, Dangas GD, Kern MJ, Rao SV, Shore-Lesserson L, et al. Evidence-based practices in the cardiac catheterization laboratory: a scientific statement from the American Heart Association. Circulation. 2021;144(5):e107-e119","journal-title":"Circulation"},{"issue":"16","key":"1744_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMcibr1409796","volume":"371","author":"E Ferrannini","year":"2014","unstructured":"Ferrannini E. The target of metformin in type 2 diabetes. N Engl J Med. 2014;371(16):1547\u20138. https:\/\/doi.org\/10.1056\/NEJMcibr1409796.","journal-title":"N Engl J Med"},{"issue":"14","key":"1744_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","volume":"14","author":"F-J Neumann","year":"2019","unstructured":"Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019;14(14):1435\u2013534.","journal-title":"EuroIntervention"},{"issue":"9","key":"1744_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.4244\/EIJV7I9A175","volume":"7","author":"A Maznyczka","year":"2012","unstructured":"Maznyczka A, Myat A, Gershlick A. Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base. EuroIntervention. 2012;7(9):1103\u201310.","journal-title":"EuroIntervention"},{"issue":"9","key":"1744_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.4244\/EIJV7I9A175","volume":"7","author":"A Maznyczka","year":"2012","unstructured":"Maznyczka A, Myat A, Gershlick A. Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base. EuroIntervention. 2012;7(9):1103\u201310.","journal-title":"EuroIntervention"},{"issue":"10315","key":"1744_CR10","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(21)02326-6","volume":"398","author":"R Mehran","year":"2021","unstructured":"Mehran R, Owen R, Chiarito M, Baber U, Sartori S, Cao D, et al. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry. Lancet. 2021;398(10315):1974\u201383.","journal-title":"Lancet"},{"issue":"2","key":"1744_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcin.2021.10.029","volume":"15","author":"JS Shavadia","year":"2022","unstructured":"Shavadia JS, Minhas R, Orvold J, Basran R, Wells C, DeVilliers J, et al. Randomized comparison of metformin continuation versus interruption following coronary angiography\/angioplasty: contemporary risk for lactic acidosis. JACC Cardiovasc Interv. 2022;15(2):233\u20136.","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"1744_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10557-015-6618-1","volume":"29","author":"RA Posma","year":"2015","unstructured":"Posma RA, Lexis CPH, Lipsic E, Nijsten MWN, Damman K, Touw DJ, et al. Effect of metformin on renal function after primary percutaneous coronary intervention in patients without diabetes presenting with ST-elevation myocardial infarction: data from the GIPS-III trial. Cardiovasc Drugs Ther. 2015;29(5):451\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"9","key":"1744_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2011.05.023","volume":"58","author":"HS Gurm","year":"2011","unstructured":"Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2011;58(9):907\u201314.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1744_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):1\u20138.","journal-title":"Crit Care"},{"issue":"9","key":"1744_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"key":"1744_CR16","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","volume":"55","author":"AS Levey","year":"2010","unstructured":"Levey AS, Stevens LA. Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010;55:622\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1744_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237\u201369.","journal-title":"Eur Heart J"},{"key":"1744_CR18","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"H Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia H, McFadden E, Farb A, et al. Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document. Circulation. 2018;137:2635\u201350.","journal-title":"Circulation"},{"issue":"23","key":"1744_CR19","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736\u201347.","journal-title":"Circulation"},{"issue":"7","key":"1744_CR20","first-page":"1393","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol. 2004;44(7):1393\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1744_CR21","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s00330-017-5247-4","volume":"28","author":"AJ van der Molen","year":"2018","unstructured":"van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, et al. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients. Eur Radiol. 2018;28(7):2856\u201369. https:\/\/doi.org\/10.1007\/s00330-017-5247-4.","journal-title":"Eur Radiol"},{"issue":"1","key":"1744_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1148\/radiol.09090690","volume":"254","author":"SK Goergen","year":"2010","unstructured":"Goergen SK, Rumbold G, Compton G, Harris C. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. Radiology. 2010;254(1):261\u20139.","journal-title":"Radiology"},{"key":"1744_CR23","first-page":"CD002967","volume-title":"Cochrane database of systematic reviews","author":"SR Salpeter","year":"2010","unstructured":"Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. In: Salpeter SR, editor. Cochrane database of systematic reviews. Chichester: John Wiley & Sons, Ltd; 2010. p. CD002967."},{"issue":"19","key":"1744_CR24","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archinternmed.2012.3630","volume":"172","author":"B Shah","year":"2012","unstructured":"Shah B, Danoff A, Radford MJ, Rolnitzky L, Sedlis SP. Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: current practice. Arch Intern Med. 2012;172(19):1514\u20136.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1744_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ccd.23185","volume":"80","author":"A Nusca","year":"2012","unstructured":"Nusca A, Patti G, Marino F, Mangiacapra F, D\u2019Ambrosio A, Di Sciascio G. Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization. Catheter Cardiovasc Interv. 2012;80(3):377\u201384. https:\/\/doi.org\/10.1002\/ccd.23185.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1744_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.amjcard.2021.06.014","volume":"155","author":"A Nusca","year":"2021","unstructured":"Nusca A, Mangiacapra F, Sticchi A, Polizzi G, D\u2019Acunto G, Ricottini E, et al. Usefulness of adding pre-procedural glycemia to the mehran score to enhance its ability to predict contrast-induced kidney injury in patients undergoing percutaneous coronary intervention development and validation of a predictive model. Am J Cardiol. 2021;155:16\u201322.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1744_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.atherosclerosis.2010.03.019","volume":"212","author":"O Morel","year":"2010","unstructured":"Morel O, Kessler L, Ohlmann P, Bareiss P. Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis. Atherosclerosis. 2010;212(2):367\u201376.","journal-title":"Atherosclerosis"},{"issue":"9","key":"1744_CR28","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.amjcard.2014.01.428","volume":"113","author":"B Shah","year":"2014","unstructured":"Shah B, Berger JS, Amoroso NS, Mai X, Lorin JD, Danoff A, et al. Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention. Am J Cardiol. 2014;113(9):1474\u201380.","journal-title":"Am J Cardiol"},{"issue":"21","key":"1744_CR29","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","volume":"281","author":"RC Turner","year":"1999","unstructured":"Turner RC, Cull CA, Frighi V, Holman RR, for the UK Prospective Diabetes Study (UKPDS) Group for the UPDS (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA. 1999;281(21):2005\u201312.","journal-title":"JAMA"},{"issue":"15","key":"1744_CR30","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.2014.3315","volume":"311","author":"CPH Lexis","year":"2014","unstructured":"Lexis CPH, Van Der Horst ICC, Lipsic E, Wieringa WG, De Boer RA, Van Den Heuvel AFM, et al. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. JAMA. 2014;311(15):1526\u201335.","journal-title":"JAMA"},{"key":"1744_CR31","doi-asserted-by":"crossref","unstructured":"Yu Q, Zhu JJ, Liu WX. Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.\u00a0BMC Cardiovasc Disord. 2020 Apr 21;20(1):187.","DOI":"10.1186\/s12872-020-01474-5"},{"issue":"2","key":"1744_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jacc.2021.09.005","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(2):197\u2013215. https:\/\/doi.org\/10.1016\/j.jacc.2021.09.005.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01744-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T13:05:51Z","timestamp":1675688751000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1744"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01744-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complies with the Declaration of Helsinki and was approved by the Ethics Committee of Humanitas Clinical and Research Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Garcia-Garcia reports the following institutional grant support: Biotronik, Boston Scientific, Medtronic, Abbott, Neovasc, Shockwave, Phillips, and Corflow. Dr. Mehran reports grants from Abbott Laboratories, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich; personal fees from Abbott Laboratories, Boston Scientific, Medscape\/WebMD, Siemens Medical Solutions, PLx Opco Inc\/dba PLx Pharma Inc, Roivant Sciences, Sanofi, Medtelligence (Janssen Scientific Affairs), Janssen Scientific Affairs; other from Abbott laboratories, other from Abiomed, other from Bristol Myers Squibb, other from Claret Medical, other from Elixir Medical, other from The Medicines eCompany, other from Spectranetics\/Philips\/Volcano Corp, other from Watermark Research Partners; non-financial support and other from Regeneron Pharmaceuticals, Idorsia Pharmaceuticals Ltd. Dr. Reimers has received speaker honoraria from Boston Scientific. Dr. Stefanini reports a research grant from Boston Scientific and speaker or consulting fees from B. Braun, Biosensors, and Boston Scientific. All other authors report no relationships relevant to the contents of this paper to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patients and\/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}}],"article-number":"28"}}